期刊
PHYTOTHERAPY RESEARCH
卷 35, 期 11, 页码 6228-6240出版社
WILEY
DOI: 10.1002/ptr.7267
关键词
apoptosis; EMT; esophageal carcinoma; luteolin; paclitaxel
资金
- National Natural Science Foundation of China [U1904156, U1904163]
- Science and Technology Innovation Talents of Henan Provincial Education Department [19IRTSTHN001]
- Zhengzhou University graduate Student independent Innovation Project
The combination of natural flavonoid compound luteolin with low-dose paclitaxel synergistically regulated the proliferation, migration, EMT, and apoptosis of esophageal cancer cells in vitro, and synergistically inhibited tumor growth in vivo without obvious toxicity. The molecular mechanisms involve the inhibition of SIRT1 for cell migration and EMT, and the activation of the mitochondrial apoptotic pathway through the ROS/JNK pathway for apoptosis induction.
Although paclitaxel is a promising frontline chemotherapy agent for various malignancies, the clinical applications have been restricted by side effects, drug resistance, and cancer metastasis. The combination of paclitaxel and other agents could be the promising strategies against malignant tumor, which enhances the antitumor effect through synergistic effects, reduces required drug concentrations, and also suppresses tumorigenesis in multiple ways. In this study, we found that luteolin, a natural flavonoid compound, combined with low-dose paclitaxel synergistically regulated the proliferation, migration, epithelial-mesenchymal transition (EMT), and apoptosis of esophageal cancer cells in vitro, as well as synergistically inhibited tumor growth without obvious toxicity in vivo. The molecular mechanism of inhibiting cell migration and EMT processes may be related to the inhibition of SIRT1, and the mechanism of apoptosis induction is associated with the reactive oxygen species (ROS)/c-Jun N-terminal kinase (JNK) pathway-mediated activation of mitochondrial apoptotic pathway.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据